Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response

A. Besse, J. Sana, R. Lakomy, L. Kren, P. Fadrus, M. Smrcka, M. Hermanova, R. Jancalek, S. Reguli, R. Lipina, M. Svoboda, P. Slampa, O. Slaby,

. 2016 ; 37 (6) : 7719-7727. [pub] 20151221

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17014188

Grantová podpora
NT13514 MZ0 CEP - Centrální evidence projektů

Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor. Despite radical surgery and radiotherapy supported by chemotherapy, the disease still remains incurable with an extremely low median survival rate of 12-15 months from the time of initial diagnosis. The main cause of treatment failure is considered to be the presence of cells that are resistant to the treatment. MicroRNAs (miRNAs) as regulators of gene expression are involved in the tumor pathogenesis, including GBM. MiR-338 is a brain-specific miRNA which has been described to target pathways involved in proliferation and differentiation. In our study, miR-338-3p and miR-338-5p were differentially expressed in GBM tissue in comparison to non-tumor brain tissue. Overexpression of miR-338-3p with miRNA mimic did not show any changes in proliferation rates in GBM cell lines (A172, T98G, U87MG). On the other hand, pre-miR-338-5p notably decreased proliferation and caused cell cycle arrest. Since radiation is currently the main treatment modality in GBM, we combined overexpression of pre-miR-338-5p with radiation, which led to significantly decreased cell proliferation, increased cell cycle arrest, and apoptosis in comparison to irradiation-only cells. To better elucidate the mechanism of action, we performed gene expression profiling analysis that revealed targets of miR-338-5p being Ndfip1, Rheb, and ppp2R5a. These genes have been described to be involved in DNA damage response, proliferation, and cell cycle regulation. To our knowledge, this is the first study to describe the role of miR-338-5p in GBM and its potential to improve the sensitivity of GBM to radiation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014188
003      
CZ-PrNML
005      
20191009123409.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13277-015-4654-x $2 doi
035    __
$a (PubMed)26692101
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Besse, Andrej $u Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Central European Institute of Technology (CEITEC), Masaryk University, University Campus Bohunice, Building A3, Kamenice 5, 625 00, Brno, Czech Republic.
245    10
$a MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response / $c A. Besse, J. Sana, R. Lakomy, L. Kren, P. Fadrus, M. Smrcka, M. Hermanova, R. Jancalek, S. Reguli, R. Lipina, M. Svoboda, P. Slampa, O. Slaby,
520    9_
$a Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor. Despite radical surgery and radiotherapy supported by chemotherapy, the disease still remains incurable with an extremely low median survival rate of 12-15 months from the time of initial diagnosis. The main cause of treatment failure is considered to be the presence of cells that are resistant to the treatment. MicroRNAs (miRNAs) as regulators of gene expression are involved in the tumor pathogenesis, including GBM. MiR-338 is a brain-specific miRNA which has been described to target pathways involved in proliferation and differentiation. In our study, miR-338-3p and miR-338-5p were differentially expressed in GBM tissue in comparison to non-tumor brain tissue. Overexpression of miR-338-3p with miRNA mimic did not show any changes in proliferation rates in GBM cell lines (A172, T98G, U87MG). On the other hand, pre-miR-338-5p notably decreased proliferation and caused cell cycle arrest. Since radiation is currently the main treatment modality in GBM, we combined overexpression of pre-miR-338-5p with radiation, which led to significantly decreased cell proliferation, increased cell cycle arrest, and apoptosis in comparison to irradiation-only cells. To better elucidate the mechanism of action, we performed gene expression profiling analysis that revealed targets of miR-338-5p being Ndfip1, Rheb, and ppp2R5a. These genes have been described to be involved in DNA damage response, proliferation, and cell cycle regulation. To our knowledge, this is the first study to describe the role of miR-338-5p in GBM and its potential to improve the sensitivity of GBM to radiation.
650    _2
$a nádory mozku $x genetika $x patologie $7 D001932
650    _2
$a transportní proteiny $x biosyntéza $x genetika $7 D002352
650    _2
$a kontrolní body buněčného cyklu $x účinky léků $x účinky záření $7 D059447
650    _2
$a buněčné dělení $x účinky léků $x účinky záření $7 D002455
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a poškození DNA $x genetika $7 D004249
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a regulace genové exprese u nádorů $x genetika $7 D015972
650    _2
$a glioblastom $x genetika $x patologie $7 D005909
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové proteiny $x biosyntéza $x genetika $7 D008565
650    _2
$a mikro RNA $x genetika $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a monomerní proteiny vázající GTP $x biosyntéza $x genetika $7 D020559
650    _2
$a nádorové proteiny $x biosyntéza $x genetika $7 D009363
650    _2
$a neuropeptidy $x biosyntéza $x genetika $7 D009479
650    _2
$a proteinfosfatasa 2 $x biosyntéza $x genetika $7 D054648
650    _2
$a RNA nádorová $x genetika $7 D012334
650    _2
$a tolerance záření $x genetika $7 D011836
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šána, Jiří $u Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Central European Institute of Technology (CEITEC), Masaryk University, University Campus Bohunice, Building A3, Kamenice 5, 625 00, Brno, Czech Republic. $7 xx0165776
700    1_
$a Lakomý, Radek $u Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic. $7 xx0164218
700    1_
$a Křen, Leoš, $u University Hospital Brno, Department of Pathology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. $d 1966- $7 xx0081918
700    1_
$a Fadrus, Pavel $u University Hospital Brno, Department of Neurosurgery, Faculty of Medicine, Masaryk University, Brno, Czech Republic. $7 xx0123566
700    1_
$a Smrčka, Martin, $u University Hospital Brno, Department of Neurosurgery, Faculty of Medicine, Masaryk University, Brno, Czech Republic. $d 1965- $7 xx0000301
700    1_
$a Hermanová, Markéta, $u First Department of Pathological Anatomy, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic. $d 1969- $7 xx0073982
700    1_
$a Jančálek, Radim, $u Department of Neurosurgery, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic. $d 1975- $7 xx0037113
700    1_
$a Reguli, Štefan $u Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic. $7 xx0231353
700    1_
$a Lipina, Radim $u Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic. $7 xx0078721
700    1_
$a Svoboda, Marek $u Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Šlampa, Pavel, $u Department of Radiation Oncology, Memorial Cancer Institute, Brno, Czech Republic. $d 1960- $7 mzk2004257405
700    1_
$a Slabý, Ondřej, $u Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic. on.slaby@gmail.com. Central European Institute of Technology (CEITEC), Masaryk University, University Campus Bohunice, Building A3, Kamenice 5, 625 00, Brno, Czech Republic. on.slaby@gmail.com. $d 1981- $7 js20030220015
773    0_
$w MED00008757 $t Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine $x 1423-0380 $g Roč. 37, č. 6 (2016), s. 7719-7727
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26692101 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20191009123827 $b ABA008
999    __
$a ok $b bmc $g 1200653 $s 974966
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 37 $c 6 $d 7719-7727 $e 20151221 $i 1423-0380 $m Tumor biology $n Tumor Biol $x MED00008757
GRA    __
$a NT13514 $p MZ0
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Možnosti archivace